ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
Enfortumab Vedotin BLA Seeking Approval in Locally Advanced/Metastatic Urothelial Cancer
3:11 PM, Tue July 16, 2019
Nivolumab And Higher-dose Ipilimumab Improves Responses in Metastatic Urothelial Carcinoma
8:42 PM, Mon July 15, 2019
Response to Checkpoint Inhibition in Urothelial Cancer May Be Affected by Autoimmune Events
5:34 PM, Tue July 2, 2019
Monitoring of ctDNA in Patients With Bladder Cancer Has Potential to Assist Therapy Selection
8:03 PM, Wed June 19, 2019
Ongoing Clinical Trials Aim to Avoid Cystectomies for Select Patients With Bladder Cancer
8:03 PM, Mon June 10, 2019
Erdafitinib Approval in Urothelial Carcinoma Opens Door to Future Targeted Therapies
4:40 PM, Mon June 10, 2019
Enfortumab Vedotin Achieves Responses in Advanced Urothelial Carcinoma
12:35 PM, Mon June 3, 2019
Expert Discusses Promising Data With Pembrolizumab for Unmet Need in NMIBC
2:05 PM, Thu May 23, 2019
